Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 2550 of 3546 entries
View as:

Carcinogenicity Study of Bupropion

Phase: N/A Priority: Normal
NCT ID: NCT01077596 Org: User:
Start: 06/30/08 End: 03/31/10 Due: 03/31/11

Proof of Mechanism Study of GSK2330811 in Diffuse Cutaneous Systemic Sclerosis

Phase: N/A Priority: Normal
NCT ID: NCT03041025 Org: User:
Start: 06/05/17 End: 07/07/20 Due: 07/07/21

Consistency & Immunogenicity Study of 3 Lots of GSK's Hib Conjugate Vaccine Versus ActHIB & Pentacel in Healthy Infants

Phase: N/A Priority: Normal
NCT ID: NCT01000974 Org: User:
Start: 06/18/10 End: 07/17/13 Due: 07/17/14

Dose Finding Study Of Oral Eltrombopag In Patients With Sarcoma Receiving Adriamycin And Ifosfamide

Phase: N/A Priority: Normal
NCT ID: NCT00358540 Org: User:
Start: 06/01/06 End: 10/22/10 Due: 10/22/11

Pharmacokinetic Study Of Valaciclovir Hydrochloride Tablets

Phase: N/A Priority: Normal
NCT ID: NCT00343278 Org: User:
Start: 07/31/05 End: 08/31/05 Due: 08/31/06

Immunogenicity and Safety Study of GlaxoSmithKline Biologicals' GSK2202083A Vaccine Administered as a Booster Dose

Phase: N/A Priority: Normal
NCT ID: NCT01171989 Org: User:
Start: 08/18/10 End: 12/03/10 Due: 12/03/11

Prevention Of Recurrence Of Atrial Fibrillation

Phase: N/A Priority: Normal
NCT ID: NCT00041496 Org: User:
Start: 11/30/01 End: 12/31/03 Due: 12/31/04

Study of Danirixin in Japanese Healthy Elderly Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT03136380 Org: User:
Start: 05/10/17 End: 07/31/17 Due: 07/31/18

Research Study To Test Carvedilol CR + Lisinopril Versus Lisinopril + Placebo In Patients With High Blood Pressure

Phase: N/A Priority: Normal
NCT ID: NCT00624065 Org: User:
Start: 03/31/08 End: 08/31/08 Due: 08/31/09

Open-Label Extension Study With REQUIP PR for Subjects From Study ROP111528

Phase: N/A Priority: Normal
NCT ID: NCT01536574 Org: User:
Start: 09/02/10 End: 03/28/12 Due: 03/28/13

A Study To Investigate GW427353 In Subjects With Irritable Bowel Syndrome (IBS)

Phase: N/A Priority: Normal
NCT ID: NCT00394186 Org: User:
Start: 08/31/06 End: - Due: -

Study to Assess the Efficacy, Immunogenicity and Safety of Liquid Human Rotavirus Vaccine, in Healthy Chinese Infants

Phase: N/A Priority: Normal
NCT ID: NCT01171963 Org: User:
Start: 08/29/10 End: 05/12/12 Due: 05/12/13

Immunogenicity and Safety of Primary and Booster Vaccination With DTPa-HBV-IPV/Hib Vaccine

Phase: N/A Priority: Normal
NCT ID: NCT00880477 Org: User:
Start: 01/31/01 End: 11/30/02 Due: 11/30/03

A Phase 3 Study to Assess the Immune Response And Safety Of Rmenb+Omv Nz In Primed Healthy Participants (10 To 20 Years Old)

Phase: N/A Priority: Normal
NCT ID: NCT06995430 Org: User:
Start: 05/27/25 End: 12/10/25 Due: 12/10/26

Study to Evaluate the Pharmacodynamics of SB-656933 in Patients With Ulcerative Colitis

Phase: N/A Priority: Normal
NCT ID: NCT00748410 Org: User:
Start: 01/22/09 End: 12/12/09 Due: 12/12/10

A Study to Investigate the Safety and Pharmacodynamics of Repeat Intranasal Administration of the TLR7 Agonist GSK2245035 in Subjects With Respiratory Allergies

Phase: N/A Priority: Normal
NCT ID: NCT01607372 Org: User:
Start: 04/30/12 End: 09/30/13 Due: 09/30/14

Immunogenicity and Safety of Two Formulations of GSK Biologicals' Pneumococcal Vaccine (2830929A and 2830930A) When Administered in Healthy Infants

Phase: N/A Priority: Normal
NCT ID: NCT01616459 Org: User:
Start: 07/11/12 End: 01/22/14 Due: 01/22/15

A Study to Demonstrate the Efficacy of GSK Biologicals' Influenza Vaccine in Adults

Phase: N/A Priority: Normal
NCT ID: NCT00363870 Org: User:
Start: 09/30/06 End: 06/30/07 Due: 06/30/08

An Efficacy Study of GlaxoSmithKline (GSK) Biologicals' Candidate Influenza Vaccine GSK2321138A in Children

Phase: N/A Priority: Normal
NCT ID: NCT01439360 Org: User:
Start: 10/01/11 End: 12/31/14 Due: 12/31/15

Ofatumumab (Humax-CD20) With CHOP (Cyclophosphamide,Doxorubicin, Vincristine, Predisolone) in Follicular Lymphoma (FL) Patients

Phase: N/A Priority: Normal
NCT ID: NCT00494780 Org: User:
Start: 06/30/07 End: 09/30/10 Due: 09/30/11

A 2 Part Study Examining Doses Of GSK961081 In Healthy Volunteers And Then In COPD Patients

Phase: N/A Priority: Normal
NCT ID: NCT00478738 Org: User:
Start: 06/30/07 End: 05/31/08 Due: 05/31/09

Study in Toddlers to Demonstrate Non-inferiority of GSK Biologicals' Hib-MenC & to Evaluate Persistence up to 5 Years.

Phase: N/A Priority: Normal
NCT ID: NCT00326118 Org: User:
Start: 06/01/06 End: 11/06/07 Due: 11/06/08

Study of HuMax-CD20, a New Drug to Treat Early Stage Non-Hodgkin´s Follicular Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00092274 Org: User:
Start: 09/30/04 End: 01/31/05 Due: 01/31/06

Immunogenicity of GSK Biologicals' Pandemic Influenza Vaccine (GSK1562902A) at Different Boosting Vaccination Schedules

Phase: N/A Priority: Normal
NCT ID: NCT00652743 Org: User:
Start: 03/23/08 End: 06/08/11 Due: 06/08/12

A Non-inferiority Study to Evaluate the Efficacy, Safety, and Tolerability of Fluticasone Propionate/Salmeterol (FSC) 250/50 Microgram (mcg) Through a Capsule-Based Inhaler and a Multi-Dose Inhaler Administered Twice Daily (BID) in Adults With Chronic Obstructive Pulmonary Disease (COPD)

Phase: N/A Priority: Normal
NCT ID: NCT01978145 Org: User:
Start: 11/14/13 End: 04/16/15 Due: 04/16/16